Related Experiment Video

Updated: Mar 22, 2026

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
17:42

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

66.2K

Response to From Systemic B-Cell Targeting to Local Immune Engineering in Islet Transplantation

Christopher S Wilson1, Daniel J Moore1,2

  • 1Department of Pediatrics, Ian Burr Division of Endocrinology and Diabetes, Vanderbilt University Medical Center, Nashville, TN.

Diabetes
|March 20, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

11.0K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.3K

Related Experiment Videos

Last Updated: Mar 22, 2026

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
17:42

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

66.2K
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

11.0K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.3K

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

86.0K
Overview
86.0K

Articles linked to this work by shared authors, journal, and citation graph.

Dual Modulation of Prostaglandin E2 Receptors EP3 and EP4 Protects β-Cell Mass in a Model of Aggressive Autoimmune Inflammation.

Diabetes·2026

B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes.

Diabetes·2025

Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1.

Diabetes care·2025

A one-week reduced-carbohydrate diet to mitigate iatrogenic peripheral hyperinsulinemia does not improve insulin sensitivity or endothelial function in a randomized, crossover trial in patients with type 1 diabetes.

Cardiovascular diabetology·2025

Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes.

Diabetes care·2023

National Pediatrician-Scientist Collaborative Workgroup comment on new ACGME requirements' impact on pediatric physician-scientists.

Pediatric research·2023

What Proportion of Antibody-Negative Type 1 Diabetes Cases Have a Nonautoimmune Etiology? A Genetics-Based Estimate.

Diabetes·2026

Irisin Gene Delivery Elicits Sustained Amelioration of Diabetes in Akita Mice via Insulin-Independent Regulation of Hepatic Glucose Metabolism.

Diabetes·2026

HGF Endogenously Produced by Pancreatic Pericytes Regulates β-Cell Function.

Diabetes·2026

Comparing the Independent Effects of Weight Loss or Exercise Training on Skeletal Muscle Lipid Localization and Insulin Sensitivity in Humans.

Diabetes·2026

Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals With Type 1 Diabetes.

Diabetes·2026

Organelle-Specific Lipid Profiles Underlie Metabolic Health in a Nutrition-Dependent Manner.

Diabetes·2026

A Microfluidic Platform for Studying Roles of Mechanical Compression in Tumor-Immune Cell Interactions in a 3D Extracellular Matrix.

Journal of visualized experiments : JoVE·2026

Nanobodies specific for Vβ11 enable detection and noninvasive imaging of antigen-specific T cells in vivo.

Journal of immunology (Baltimore, Md. : 1950)·2026

Organization from cell to tissue derived delivery systems for immunotherapy.

Materials today. Bio·2026

Corrigendum to "Disappearance of the Defining Organized Ultrastructural Lesion in Chronic Lymphocytic Leukemia-Associated Monoclonal Immunotactoid Glomerulopathy After Ibrutinib Therapy" [Kidney International Reports Volume 11, Issue 8, August 2026, 106643].

Kidney international reports·2026

Proteomic profiling and comparative hemotoxicity of Gloydius brevicaudus and Deinagkistrodon acutus venoms: insights into functional convergence.

The journal of venomous animals and toxins including tropical diseases·2026

Correction: The gut-liver-immune axis: structural basis, cellular architecture, molecular mediators, and disease-specific manifestations.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us